Microaxial flow pump circulatory support with the Impella device during percutaneous coronary intervention (PCI) didn't help outcomes for complex patients not in cardiogenic shock, two randomized ...

In carefully selected patients with CTOs, symptom-driven PCI does provide a benefit when done by experienced operators.

Aspirin is considered the cornerstone of secondary prevention of coronary artery disease. However, the evidence supporting aspirin was largely generated before the advent of modern pharmacological and ...

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percutaneous coronary intervention (PCI), also known as coronary ...

Home-delivered groceries tailored to the low-sodium Dietary Approaches to Stop Hypertension diet improved BP among Black adults already being treated for hypertension, according to results from the ...

The ALL-RISE Trial included 1930 patients enrolled across 59 global sites in North America, Asia, Europe and the Middle East. Patients presenting with coronary stenoses of intermediate significance ...

Results support initiation of Phase 2b clinical trial of tonlamarsen in patients with acute severe hypertension SOUTH SAN FRANCISCO, Calif., & PRINCETON, N.J.-- (BUSINESS WIRE)--March 28, 2026-- ...

A major advance for the treatment of intermediate-risk pulmonary embolism (PE) arrived with HI-PEITHO's landmark report on ultrasound-facilitated, catheter-directed thrombolysis (CDT). In this hard-to ...

In the Phase 2 part of the AMETHYST study, litifilimab met the primary endpoint of reduction of disease activity in people living with CLE at ...

Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses ...